Role of site-selective cAMP analogs in the control and reversal of malignancy
- 31 December 1991
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 50 (1), 1-33
- https://doi.org/10.1016/0163-7258(91)90071-s
Abstract
No abstract availableKeywords
This publication has 218 references indexed in Scilit:
- Suppression of malignancy targeting the intracellular signal transducing proteins of cAMP: The use of site-selective cAMP analogs, antisense strategy, and gene transferLife Sciences, 1991
- Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREBNature, 1988
- Human megakaryocytes. V. Changes in the phenotypic profile of differentiating megakaryocytes.The Journal of Experimental Medicine, 1985
- cAMP Receptor Proteins and protein Kinases in Human Lymphocytes: Fundamental Alterations in Chronic Lymphocytic Leukemia CellsEuropean Journal of Biochemistry, 1981
- Nuclear translocation of cAMP-dependent protein kinaseExperimental Cell Research, 1981
- Kinase-negative mutants of S49 mouse lymphoma cells carry a trans-dominant mutation affecting expression of cAMP-dependent protein kinaseCell, 1978
- Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. The 10th Walter Hubert LectureBritish Journal of Cancer, 1978
- Effects of cell density and cell growth alterations on cyclic nucleotide levels in cultured human diploid fibroblastsExperimental Cell Research, 1978
- The positive control of cell proliferation by the interplay of calcium ions and cyclic nucleotides. A reviewIn Vitro Cellular & Developmental Biology - Plant, 1976
- Adenosine 3′,5′-Monophosphate: Regional Differences in Chick Embryos at the Head Process StageScience, 1972